Mutational analyses of 13 genes commonly mutated in myeloid malignancies, including Janus Kinase 2 (JAK2), calreticulin (CALR), thrombopoietin receptor (MPL), and colony‐stimulating factor 3 receptor (CSF3R) was negative on peripheral blood testing. Here, MPL is linked to myeloid neoplasm.